CD32
CD32
HIV cure
HIV latency
HIV persistence
HIV reservoir
antiretroviral therapy
biomarker
Journal
Cell reports
ISSN: 2211-1247
Titre abrégé: Cell Rep
Pays: United States
ID NLM: 101573691
Informations de publication
Date de publication:
18 02 2020
18 02 2020
Historique:
received:
24
06
2019
revised:
25
11
2019
accepted:
21
01
2020
pubmed:
23
2
2020
medline:
10
3
2021
entrez:
21
2
2020
Statut:
ppublish
Résumé
The HIV latent reservoir forms the major hurdle to an HIV cure. The discovery of CD32 as marker of this reservoir has aroused much interest, but subsequent reports have challenged this finding. Here, we observe a positive correlation between the percentages of CD32
Identifiants
pubmed: 32075737
pii: S2211-1247(20)30096-6
doi: 10.1016/j.celrep.2020.01.071
pmc: PMC7050565
mid: NIHMS1563621
pii:
doi:
Substances chimiques
DNA, Viral
0
Receptors, IgG
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2284-2296.e3Subventions
Organisme : NIAID NIH HHS
ID : R01 AI145045
Pays : United States
Informations de copyright
Copyright © 2020 The Author(s). Published by Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Interests The authors declare no competing interests.